Item 2.02  Results of Operations and Financial Condition
On August 9, 2021, Dicerna Pharmaceuticals, Inc., a Delaware corporation (the
"Company"), issued a press release announcing its financial and operational
results for the quarter ended June 30, 2021. A copy of the press release is
furnished herewith as Exhibit 99.1.
The information in Item 2.02 of this Form 8-K (including Exhibit 99.1 attached
hereto) is being furnished and shall not be deemed "filed" for purposes of
Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange
Act"), or otherwise subject to the liability of that section, nor shall such
information be deemed to be incorporated by reference in any registration
statement or other document filed under the Securities Act of 1933, as amended,
or the Exchange Act, except as otherwise stated in such filing.
Item 9.01  Financial Statements and Exhibits
(d) Exhibits
   Exhibit
     No.                                              Description
    99.1              Press Release, entitled "Dicerna Announces Second Quarter 2021 Financial
                    Results and Provides a Business Update.    "
     104            Cover Page Interactive Data File (embedded within the Inline XBRL document).

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses